Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2005
12/15/2005US20050276789 Immunostimulatory oligonucleotides and uses thereof
12/15/2005DE102004025731A1 Antibakterielle Amid-Makrozyklen III Antibacterial amide macrocycles III
12/15/2005CA2776051A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2775807A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2569514A1 Oral preparations and process for production thereof
12/15/2005CA2568671A1 Use of imatinib to treat liver disorders and viral infections
12/15/2005CA2568415A1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
12/15/2005CA2568162A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2567803A1 Injectable pharmaceutical suspension comprising posaconazole
12/15/2005CA2562713A1 Phosphonate analogs of hiv integrase inhibitor compounds
12/15/2005CA2562332A1 Amino-propanol derivatives
12/14/2005EP1605061A1 Neisseria genomic sequences and methods of their use
12/14/2005EP1605052A2 A method for producing influenza hemagglutinin multivalent vaccines
12/14/2005EP1605047A1 Chimeric and/or growth-restricted flaviviruses
12/14/2005EP1604993A1 Inhibitors
12/14/2005EP1604984A1 Water-soluble phenylpyridazine derivative and medicine containing the same
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604981A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/14/2005EP1604688A1 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy
12/14/2005EP1604684A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
12/14/2005EP1604660A1 Medicinal composition for treating infection with drug-resistant staphylococcus aureus
12/14/2005EP1603950A2 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
12/14/2005EP1603903A1 Antibacterial oxalidinones
12/14/2005EP1603888A1 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazoline-4-yl) acetic acids as anti-viral agents, especially against cytomegalo viruses
12/14/2005EP1603887A1 Hiv replication inhibiting pyrimidines and triazines
12/14/2005EP1603881A2 Substituted thiophenes with antibacterial activity
12/14/2005EP1603563A1 Resonance modulator for diagnosis and therapy
12/14/2005EP1603546A1 Glycinamide derivative for inhibiting hiv replication
12/14/2005EP1603409A2 Salutary compositions consisting of fungi containing lipids and thiocyanates
12/14/2005EP1492766A4 Improved cc-1065 analog synthesis
12/14/2005EP1438290B1 Cyclohept b!indole derivatives as spla2 inhibitors
12/14/2005EP1326895B1 Monoclonal antibodies directed against hepatitis b viruses
12/14/2005EP1311296B1 Solution of an oxazolidinone antibiotic drug
12/14/2005EP1267880B1 Low dose entecavir formulation and use
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1259923B1 Anti-infective agents useful against mulitidrug-resistant strains of bacteria
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1227084B1 Drug discharge pump inhibitors
12/14/2005EP1217989B1 Vaccines for oral use which contain liposome-entrapped dna
12/14/2005EP1121355B1 Quinoline derivatives and their use as antibacterial agents
12/14/2005EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof
12/14/2005EP1091975B1 Novel cyclosporin with improved activity profile
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1080198B1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/14/2005EP0970198B1 Micro-organisms with increased production of clavulanic acid
12/14/2005EP0765357B1 Antiviral dendrimers
12/14/2005EP0506830B1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
12/14/2005CN1708482A N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1708481A N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1708304A Use of piperazine sulfonic acid derivatives as CCR1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders
12/14/2005CN1706939A Antinuclear polyhedron virus transgenic silkworm and generating method thereof
12/14/2005CN1706855A Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
12/14/2005CN1706838A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/14/2005CN1706833A Formyl peptide-like acceptor-1 regulator and its prepn and use
12/14/2005CN1706824A Compound as CCR5 agonist
12/14/2005CN1231598C Process for recombining aviadenovirus
12/14/2005CN1231589C Eukaryotic gene expression cassette and uses thereof
12/14/2005CN1231578C Attenuated virus of ox's viral diarrhea
12/14/2005CN1231573C Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231466C New piperidine derivatives
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/14/2005CN1231261C Compound alliin enteric solubility capsule
12/14/2005CN1231258C Interferon lozenge ice block and making method and use thereof
12/14/2005CN1231254C Medicine for treating tuberculosis and method for preparing the same
12/14/2005CN1231242C Medication composition for children 's virus pneumonia and its preparation method
12/14/2005CN1231239C Medicine for curing hydrocephalus, brain abscess and brain tumor and preparation process thereof
12/14/2005CN1231218C Use of medicinal composition in preparing medicine for treating middle ear infections
12/14/2005CN1231216C Aspartic acid lomefloxacin powder and preparing method thereof
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974831 sPLA2 inhibitors
12/13/2005US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974809 Inhibitors of interleukin 1-β converting enzyme
12/13/2005US6974797 Bactericides for drug resistant bacteria
12/13/2005US6974686 Recombinant tryptophan mutants of influenza
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005US6974581 Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
12/13/2005US6974576 Extracts provided by the present invention have a higher immune stimulatory activity than extracts prepared and used in the art
12/13/2005CA2324403C Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
12/13/2005CA2280151C Arylsulfonyl hydroxamic acid derivatives
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/13/2005CA2171003C Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo[1,2,4]triazolo[1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation
12/13/2005CA2001328C Borrelia antigen
12/08/2005WO2005116036A1 Curcumol derivatives, the compositions comprising the same and the use of the same in the manufacture of medicament
12/08/2005WO2005116013A1 Crystal of pharmaceutical compound
12/08/2005WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/08/2005WO2005115460A1 A method of producing polypeptides from plant protein and use of polypeptides
12/08/2005WO2005115436A1 Soluble lfa-3 polypeptide for treating viral disorders
12/08/2005WO2005115424A1 Enhancement of antitubercular activity of extracts of salicornia brachiata
12/08/2005WO2005080549A3 Trioxacarcins and their use against infections
12/08/2005WO2005074968A3 Medical use of basic peptides
12/08/2005WO2004093798A3 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272784 Inhibitors of bacterial Type III protein secretion systems
1 ... 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 ... 1798